<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04996134</url>
  </required_header>
  <id_info>
    <org_study_id>17-123 (16-817)</org_study_id>
    <nct_id>NCT04996134</nct_id>
  </id_info>
  <brief_title>Domperidone Expanded Access Treatment Program</brief_title>
  <official_title>Domperidone Protocol - FDA Expanded Access Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aurora Health Care</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aurora Health Care</source>
  <brief_summary>
    <textblock>
      To allow the use of domperidone by patients with gastrointestinal disorders who have failed&#xD;
      standard therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To provide oral domperidone to patients â‰¥12 years of age where, according to the&#xD;
      investigator's judgment, a prokinetic effect is needed for the relief of refractory&#xD;
      gastroesophageal reflux disease with upper gastrointestinal (GI) symptoms, gastroparesis, and&#xD;
      chronic constipation in patients whom the potential benefit may outweigh the risk of&#xD;
      cardiovascular adverse reactions including QT prolongation, Torsades de Pointes, and death.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Available</overall_status>
  <study_type>Expanded Access</study_type>
  <has_expanded_access>No</has_expanded_access>
  <expanded_access_info>
    <expanded_access_type_treatment>Yes</expanded_access_type_treatment>
  </expanded_access_info>
  <condition>Gastroparesis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Domperidone Oral Product</intervention_name>
    <description>10-30 mg of oral domperidone administered QID.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female&#xD;
&#xD;
          2. Age 12 and older&#xD;
&#xD;
          3. Symptoms or manifestations secondary to GERD (e.g., persistent esophagitis, heartburn,&#xD;
             upper airway signs or symptoms or respiratory symptoms), gastrointestinal motility&#xD;
             disorders such as nausea, vomiting, severe dyspepsia or severe chronic constipation&#xD;
             that are refractory to standard therapy.&#xD;
&#xD;
          4. Patients must have a comprehensive evaluation to eliminate other causes of their&#xD;
             symptoms.&#xD;
&#xD;
          5. Patient has signed informed consent for the administration of domperidone that informs&#xD;
             the patient of potential adverse events&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        History of, or current, arrhythmias including ventricular tachycardia, ventricular&#xD;
        fibrillation and Torsades de Pointes. Patients with minor forms of ectopy (PACs) are not&#xD;
        necessarily excluded.&#xD;
&#xD;
          1. Clinically significant bradycardia, sinus node dysfunction, or heart block. Prolonged&#xD;
             QTc (QTc &gt; 450 milliseconds for males, QTc&gt;470 milliseconds for females).&#xD;
&#xD;
          2. Hepatic dysfunction&#xD;
&#xD;
          3. Renal insufficiency&#xD;
&#xD;
          4. Clinically significant electrolyte disorders.&#xD;
&#xD;
          5. Gastrointestinal hemorrhage or obstruction&#xD;
&#xD;
          6. Presence of a prolactinoma (prolactin-releasing pituitary tumor).&#xD;
&#xD;
          7. Pregnant or breast feeding female&#xD;
&#xD;
          8. Known allergy to domperidone&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Taylor Romdenne, BS, CCRP</last_name>
    <phone>920-288-3127</phone>
    <email>Taylor.Romdenne@aah.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aurora BayCare Medical Center</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54311</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Taylor Romdenne, BS, CCRP</last_name>
      <phone>920-288-3127</phone>
      <email>Taylor.Romdenne@aah.org</email>
    </contact>
    <investigator>
      <last_name>John J Bosco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 3, 2021</study_first_submitted>
  <study_first_submitted_qc>August 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2021</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aurora Health Care</investigator_affiliation>
    <investigator_full_name>John Bosco</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Domperidone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

